CBD
Cannabidiol
The major cannabinoid in the line. Clinical literature is broader than for minor cannabinoids, but any effect depends on formulation, dose and clinical context.
View study · PubMed Explore further · CBDGREENLION · ADVANCED HEMP SCIENCE
Precision
The science of rare.
The essence of Precision.
Relief, Harmony and Balance. CBD and rare cannabinoids in three distinctive formulations, giving prescribers more composition options.
Explore the three profilesPRECISION LINE mg mL · formulations
PRECISION / RARE CANNABINOIDS
Meet the rare cannabinoids in Precision.
CBG, CBC, CBN and other minor forms add diversity beyond CBD. Explore the compounds in the three formulas and the research behind each. Rarity describes composition; suitability depends on clinical assessment.
CBG
Cannabigerol
A minor cannabinoid. Experimental studies investigate inflammatory and neurological pathways; clinical evidence remains limited.
View study · PubMed Explore further · CBGCBC
Cannabichromene
A rare cannabinoid. Experimental studies investigate pathways related to inflammation and nociception; this is not a treatment indication.
View study · PubMed Explore further · CBCCBN
Cannabinol
A rare cannabinoid investigated in clinical sleep studies. Findings vary with the dose and formulation studied, and cannot be generalized to every product.
View study · PubMed Explore further · CBNCBL
Cannabicyclol
A rare cannabinoid. A 2025 experimental study investigated its interaction with the serotonin 5-HT1A receptor. This does not demonstrate clinical efficacy or establish effects of the formulation.
View study · PubMed Explore further · CBLΔ9-THC
Delta-9-tetrahydrocannabinol
A cannabinoid with psychoactive potential and regulatory relevance. Confirm concentration in the lot COA and with the prescriber.
View study · PubMed Explore further · Δ9-THCTHCA + THCV
Acidic and varin forms
A combination shown in the Relief reference profile. Interpretation should consider the lot composition and prescriber guidance.
View study · PubMed Additional reference · PubMed Explore further · THCAExplore further · THCVTerpenes
Terpenes
Not cannabinoids. They are aromatic compounds in the formulation profile; confirm their presence in the lot COA.
View study · PubMed Additional reference · PubMed Explore further · TerpenesCBG-A
Cannabigerolic acid
An acidic form and precursor to other cannabinoids. It is a rare compound, still studied mainly in experimental models.
View study · PubMed Explore further · CBG-ACBD-A
Cannabidiolic acid
The acidic form of CBD, investigated in experimental models involving serotonin 5-HT1A receptors. Clinical evidence remains limited.
View study · PubMed Explore further · CBD-ACBDV
Cannabidivarin
A rare varin cannabinoid investigated in exploratory clinical studies. Evidence of its effects in humans remains limited.
View study · PubMed Explore further · CBDVCBC-A
Cannabichromenic acid
The acidic form of CBC. In vitro studies investigate its interaction with cellular transporters ABCG2 and ABCB1. Laboratory findings do not establish a clinical indication.
View study · PubMed Explore further · CBC-AΔ8-THC
Delta-8-tetrahydrocannabinol
A cannabinoid with psychoactive potential and regulatory relevance. Confirm concentration in the lot COA and with the prescriber.
View study · PubMed Explore further · Δ8-THCTHCV
Tetrahydrocannabivarin
A rare varin cannabinoid studied in pilot trials of metabolic parameters. The findings are preliminary and require confirmation in larger studies.
View study · PubMed Explore further · THCVFOR PHYSICIANS